- Clinical Trials
- April 2025
- 100 Pages
Global
From €1793EUR$2,000USD£1,553GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2689EUR$3,000USD£2,330GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2689EUR$3,000USD£2,330GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1345EUR$1,500USD£1,165GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1345EUR$1,500USD£1,165GBP
- Clinical Trials
- April 2025
- 70 Pages
Global
From €1345EUR$1,500USD£1,165GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1345EUR$1,500USD£1,165GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1345EUR$1,500USD£1,165GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1345EUR$1,500USD£1,165GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1345EUR$1,500USD£1,165GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1121EUR$1,250USD£971GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1121EUR$1,250USD£971GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1121EUR$1,250USD£971GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1121EUR$1,250USD£971GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1121EUR$1,250USD£971GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1121EUR$1,250USD£971GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1121EUR$1,250USD£971GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1121EUR$1,250USD£971GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1121EUR$1,250USD£971GBP
- Report
- March 2026
- 271 Pages
Global
From €5244EUR$5,850USD£4,544GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more